G

Galmed Pharmaceuticals Ltd
D

GLMD

1.79000
USD
-0.17
(-8.67%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
4,041,881
أصول ذات صلة
A
ALKS
0.830
(3.17%)
27.000 USD
A
ARDX
-0.06000
(-1.40%)
4.21500 USD
C
CRIS
-0.07000
(-3.85%)
1.75000 USD
I
IMAB
-0.18000
(-9.68%)
1.68000 USD
L
LXRX
-0.03000
(-2.77%)
1.05500 USD
R
RGNX
-0.36500
(-4.15%)
8.42500 USD
S
SRRK
0.210
(0.57%)
37.280 USD
V
VYGR
-0.08000
(-2.44%)
3.19500 USD
المزيد
الأخبار المقالات

العنوان: Galmed Pharmaceuticals Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.